Discontinuation report AVAXIM
| Report ID | 257527 |
| Drug Identification Number | 02237792 |
| Brand name | AVAXIM |
| Common or Proper name | test |
| Company Name | SANOFI PASTEUR LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS A VIRUS, INACTIVATED |
| Strength(s) | 160UNIT |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10ml |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | 2025-04-06 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | test |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
| Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-10-08 | French | Compare |
| v1 | 2025-10-08 | English | Compare |
Showing 1 to 2 of 2